DRIEHAUS CAPITAL MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
DRIEHAUS CAPITAL MANAGEMENT LLC portfolio value:
$23.64M
portfolio value
DRIEHAUS CAPITAL MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +127.47% | 124.77K shares | 14.10M | $106.21 | 222.65K |
| Q2 2022 | share | Increase | 0.00% | 97.88K shares | 9.54M | $97.48 | 97.88K |
| Q3 2020 | share | Decrease | -100.00% | -2.58K shares | -315K | $96.16 | 0 |
| Q2 2020 | share | Decrease | -62.93% | -4.38K shares | -289K | $122 | 2.58K |
| Q1 2020 | share | Decrease | -64.95% | -12.92K shares | -1.53M | $86.55 | 6.97K |
| Q4 2019 | share | Decrease | -36.78% | -11.57K shares | -697K | $107.49 | 19.9K |
| Q3 2019 | share | Increase | 0.00% | 31.47K shares | 2.83M | $90.11 | 31.47K |
| Q4 2018 | share | Decrease | -100.00% | -17.89K shares | -2.2M | $71.41 | 0 |
| Q3 2018 | share | Increase | +22.35% | 3.26K shares | 763K | $122.95 | 17.89K |
| Q2 2018 | share | Decrease | -11.17% | -1.83K shares | 72K | $98.24 | 14.62K |
| Q1 2018 | share | Increase | +24.47% | 3.23K shares | 339K | $82.93 | 16.46K |
| Q4 2017 | share | Decrease | -7.51% | -1.07K shares | 150K | $77.59 | 13.22K |
| Q3 2017 | share | Increase | 0.00% | 14.3K shares | 876K | $61.28 | 14.3K |